Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar lola99999 (< 20) Submitted: 12/16/2009 9:34:30 PM : Outperform Start Price: $2.27 ALXA Score: -103.48

ALXA

Featured Broker Partners


Advertisement